Search

Your search keyword '"Sridhar, S. S."' showing total 263 results

Search Constraints

Start Over You searched for: Author "Sridhar, S. S." Remove constraint Author: "Sridhar, S. S."
263 results on '"Sridhar, S. S."'

Search Results

51. A Deep Learning Regression Model for Photonic Crystal Fiber Sensor With XAI Feature Selection and Analysis

56. Low-frequency observations of the Giant Radio Galaxy NGC 6251

58. CHANG-ES XXIII: influence of a galactic wind in NGC 5775.

59. Warped diffusive radio halo around the quiescent spiral edge-on galaxy NGC 4565

60. The LOFAR Two-metre Sky Survey

61. LOFAR MSSS: Flattening low-frequency radio continuum spectra of nearby galaxies

62. Reliable detection and characterization of low-frequency polarized sources in the LOFAR M51 field

63. Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy

65. The LOFAR Two-metre Sky Survey:I. Survey description and preliminary data release

66. LOFAR MSSS: The scaling relation between AGN cavity power and radio luminosity at low radio frequencies

68. LOFAR MSSS: Discovery of a 2.56 Mpc giant radio galaxy associated with a disturbed galaxy group

69. The LOFAR Two-metre Sky Survey

70. Faraday tomography of the local interstellar medium with LOFAR: Galactic foregrounds towards IC 342

72. A network approach to developing immuno-oncology combinations in Canada.

73. LOFAR 150-MHz observations of the Boötes field: catalogue and source counts

74. A plethora of diffuse steep spectrum radio sources in Abell 2034 revealed by LOFAR

75. LOFAR FACET CALIBRATION

76. LOFAR, VLA, ANDCHANDRAOBSERVATIONS OF THE TOOTHBRUSH GALAXY CLUSTER

80. Evaluation of second-line response to targeted therapy following progression on first-line cediranib, an oral pan-vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor (TKI), in advanced renal cell carcinoma (RCC).

82. Preoperative sorafenib (Sor) and cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC).

96. Activity of cediranib (AZD2171) in patients (pts) with previously untreated metastatic renal cell cancer (RCC). A phase II trial of the PMH Consortium

97. Phase II study of the angiogenesis inhibitor AZD2171 in first line, progressive, unresectable, advanced metastatic renal cell carcinoma (RCC): A trial of the PMH Phase II Consortium

100. VizieR Online Data Catalog: Bootes field LOFAR 150-MHz observations (Williams+, 2016)

Catalog

Books, media, physical & digital resources